Medivir Aktiebolag

Kvartalsrapporter

Visar 1 grupper

  1. Kvartalsrapport Q1 2026

    ENSV
    →

    Financial Position

    • Medivir significantly strengthened its financial position during the quarter, primarily through a directed share issue of SEK 45 million to Carl Bennet AB.
    • Cash and cash equivalents at the end of the period amounted to SEK 149.1 million, compared to SEK 35.1 million in the same period last year.
    • Net turnover for the quarter was SEK 1.0 million…

    Öppna rapport